Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xie, XP; Liu, Y; Liu, JY; Zhang, XW; Zou, J; Fontes-Garfias, CR; Xia, HJ; Swanson, KA; Cutler, M; Cooper, D; Menachery, VD; Weaver, SC; Dormitzer, PR; Shi, PY
Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Dormitzer, PR (corresponding author), Pfizer, Pearl River, NY 10965 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY
NATURE MEDICINE, ; ():